According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings are โฌ0.19 Billion. In 2023 the company made an earning of โฌ37.16 Million, an increase over its 2022 earnings that were of -โฌ0.2 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -โฌ0.2 Billion | -628.7% |
2023 | โฌ37.16 M | -119.27% |
2022 | -โฌ0.2 Billion | 143.41% |
2021 | -โฌ79.24 Million |